Skip to Main Content
×
Quiver Logo Get a Free Trial on Quiver Premium Today!
Back to News

QIAGEN Slides as CEO Change Keeps Focus on Leadership Transition and Strategic Review

None

QIAGEN N.V. (QGEN) is down 3.3% today. Here is some analysis on what might have caused this price movement. ([webdisclosure.com](https://www.webdisclosure.com/press-release/qiagen-nv-etr-qia-eqs-adhoc-qiagen-nv-qiagen-appoints-jonathan-m-pratt-as-chief-executive-officer-VrlaSHDGF3d?utm_source=openai))

Analysis: The most likely catalyst is QIAGEN’s announcement that Jonathan M. Pratt will become chief executive officer on September 1, replacing Thierry Bernard, while the company also said its strategic review is still ongoing. This could be because investors are treating the leadership change as a new layer of uncertainty, even though management reaffirmed its outlook for the third quarter and full-year 2026. ([webdisclosure.com](https://www.webdisclosure.com/press-release/qiagen-nv-etr-qia-eqs-adhoc-qiagen-nv-qiagen-appoints-jonathan-m-pratt-as-chief-executive-officer-VrlaSHDGF3d?utm_source=openai))

Details:

  • QIAGEN said Pratt, most recently the head of Filtration Group, will take over as CEO on September 1, while Bernard will help with the transition through the end of the year. ([webdisclosure.com](https://www.webdisclosure.com/press-release/qiagen-nv-etr-qia-eqs-adhoc-qiagen-nv-qiagen-appoints-jonathan-m-pratt-as-chief-executive-officer-VrlaSHDGF3d?utm_source=openai))
  • In the same announcement, the company reaffirmed its outlook for Q3 and full-year 2026 rather than changing guidance. ([webdisclosure.com](https://www.webdisclosure.com/press-release/qiagen-nv-etr-qia-eqs-adhoc-qiagen-nv-qiagen-appoints-jonathan-m-pratt-as-chief-executive-officer-VrlaSHDGF3d?utm_source=openai))
  • QIAGEN also said its supervisory board continues to evaluate strategic opportunities with outside advisers, keeping takeover or restructuring expectations in the background. ([webdisclosure.com](https://www.webdisclosure.com/press-release/qiagen-nv-etr-qia-eqs-adhoc-qiagen-nv-qiagen-appoints-jonathan-m-pratt-as-chief-executive-officer-VrlaSHDGF3d?utm_source=openai))
  • Earlier this month, QIAGEN had posted Q2 results above its own outlook, so today’s weakness appears more tied to leadership and deal-process interpretation than to a fresh deterioration in operating performance. ([corporate.qiagen.com](https://corporate.qiagen.com/English/newsroom/press-releases/press-release-details/2026/QIAGEN-Exceeds-Q2-2026-Outlook-as-Pillars-Deliver-Solid-Sales-Growth-Reaffirms-Full-Year-Outlook/default.aspx?utm_source=openai))
  • Sources:

    QIAGEN, Yahoo Finance, Boursorama

    Disclaimer: This price movement analysis was generated with the help of AI. Please double-check the information provided for mistakes.

    $QGEN Hedge Fund Activity

    We have seen 217 institutional investors add shares of $QGEN stock to their portfolio, and 154 decrease their positions in their most recent quarter.

    Here are some of the largest recent moves:

    • PRINCIPAL FINANCIAL GROUP INC added 6,643,158 shares (+120281.7%) to their portfolio in Q2 2026, for an estimated $259,747,477
    • NORGES BANK added 4,325,135 shares (+inf%) to their portfolio in Q2 2026, for an estimated $169,112,778
    • BOSTON PARTNERS removed 3,597,424 shares (-99.2%) from their portfolio in Q2 2026, for an estimated $140,659,278
    • DEUTSCHE BANK AG\ removed 3,416,149 shares (-61.0%) from their portfolio in Q2 2026, for an estimated $133,571,425
    • MILLENNIUM MANAGEMENT LLC added 3,247,768 shares (+543.3%) to their portfolio in Q2 2026, for an estimated $126,987,728
    • HELIKON INVESTMENTS LTD added 3,085,155 shares (+inf%) to their portfolio in Q2 2026, for an estimated $120,629,560
    • GOLDMAN SACHS GROUP INC added 3,052,347 shares (+219.4%) to their portfolio in Q2 2026, for an estimated $119,346,767

    To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint.

    $QGEN Price Targets

    Multiple analysts have issued price targets for $QGEN recently. We have seen 8 analysts offer price targets for $QGEN in the last 6 months, with a median target of $41.0.

    Here are some recent targets:

    • Steve Beuchaw from Morgan Stanley set a target price of $42.0 on 06/23/2026
    • Daniel Arias from Stifel set a target price of $36.0 on 05/18/2026
    • Dan Brennan from TD Cowen set a target price of $40.0 on 05/07/2026
    • Catherine Schulte from Baird set a target price of $43.0 on 04/29/2026
    • Luke Sergott from Barclays set a target price of $38.0 on 04/29/2026
    • Patrick Donnelly from Citigroup set a target price of $38.0 on 04/29/2026
    • Casey Woodring from JP Morgan set a target price of $45.0 on 04/29/2026

    This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.

    Add Quiver Quantitative to your preferred sources on Google Google News Logo

    Suggested Articles